Skip to content

Clinical trials

Phase 2 Opioid-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 2 Country / region: United States Clear all

190 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20024
20031
20046
20057
20065
20075
20086
20091
20104
20126
20135
20141
20155
20172
20183
20196
20206
202110
202211
20234
20249
20259
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126
Recruiting22
Withdrawn16
Terminated15
Not yet recruiting4
Unknown status4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)34
Yale University21
New York State Psychiatric Institute14
Johns Hopkins University13
University of Vermont8
University of Chicago7
University of Colorado, Denver7
Brigham and Women's Hospital6
Indivior Inc.6
University of Pennsylvania5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders190
Substance-Related Disorders34
Heroin Dependence15
Chronic Pain11
Cocaine-Related Disorders10
Pain7
Agnosia5
HIV Infections4
Narcotic-Related Disorders4
Acquired Immunodeficiency Syndrome3

Trials

Showing 1 to 25 of 190. Each trial links to its page on Pharma Observatory.

90 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.